Description

Jakafi is a medication used to treat certain types of blood cancers, specifically myelofibrosis and polycythemia vera. It works by inhibiting specific pathways that lead to the proliferation of abnormal blood cells.

Interpreter Notes

Interpreters should be aware that Jakafi may be referred to by its generic name, ruxolitinib, in some contexts. It is important to maintain a formal register when discussing this medication, as it is used in serious medical conditions. Avoid colloquial terms that may not be understood in clinical settings.

Example Sentences

EN: The doctor prescribed Jakafi to manage the patient's myelofibrosis.

ES: El médico recetó Jakafi para manejar la mielofibrosis del paciente.

Common Interpreter Mistakes

Confusing Jakafi with other cancer medications; mispronouncing Jakafi as 'Jaca-fi'; using informal language when discussing the medication.